[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R)-15-[3-[5-[(3,5-dichloropyridin-4-yl)carbamoyl]-2-methoxyphenoxy]propyl]-8-[(2S,3R,4S,6R)-4-[[2-(dimethylamino)acetyl]-methylamino]-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate | 1266347-97-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R)-15-[3-[5-[(3,5-dichloropyridin-4-yl)carbamoyl]-2-methoxyphenoxy]propyl]-8-[(2S,3R,4S,6R)-4-[[2-(dimethylamino)acetyl]-methylamino]-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate
• CAS: 1266347-97-0
• 化学式: C₅₆H₈₂Cl₂N₆O₁₆
• 分子量: 1166.2
• InChiKey: FGQFYXZEAIBDKX-FOMCEGKTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  80
• 可旋转键数：
  19
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  244
• 氢给体数：
  2
• 氢受体数：
  19

反应信息

• 作为产物：
  描述：

  [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-15-[3-[5-[(3,5-dichloropyridin-4-yl)carbamoyl]-2-methoxyphenoxy]propyl]-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate 在 甲醇 、 碘 、 sodium acetate 、 N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.08h， 生成 [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R)-15-[3-[5-[(3,5-dichloropyridin-4-yl)carbamoyl]-2-methoxyphenoxy]propyl]-8-[(2S,3R,4S,6R)-4-[[2-(dimethylamino)acetyl]-methylamino]-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate
  参考文献：
  名称：

  [EN] NEW MACROLIDES AND THEIR USE
  [FR] NOUVEAUX MACROLIDES ET LEUR UTILISATION

  摘要：

  该发明涉及公式（I）的大环内酯化合物，所述化合物的用途为药物，特别用于治疗或预防炎症和过敏性疾病，含有该化合物的药物组合物以及其制备方法。该发明特别涉及具有抗炎活性的大环内酯化合物，主要通过磷酸二酯酶4（PDE4）的抑制介导，使其在治疗和/或预防慢性阻塞性肺疾病（COPD）、哮喘、类风湿关节炎、特应性皮炎或炎症性肠病等炎症和过敏性疾病，以及癌症等增殖性疾病方面具有用途。

  公开号：

  WO2011018510A1

文献信息

• NEW MACROLIDES AND THEIR USE
  申请人：Kellenberger Johannes Laurenz

  公开号：US20120277174A1

  公开（公告）日：2012-11-01

  The invention relates to macrolide compounds of formula (I), the use of said compounds as medicaments, in particular for the treatment or prevention of inflammatory and allergic diseases, pharmaceutical compositions containing said compounds and to processes for their preparation. The invention relates in particular to macrolide compounds with antiinflammatory activity mediated primarily through inhibition of phosphodiesterase 4 (PDE4) which makes them useful for the treatment and/or prevention of inflammatory and allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, atopic dermatitis or inflammatory bowel disease or proliferative diseases such as cancer.
• US8865662B2
  申请人：——

  公开号：US8865662B2

  公开（公告）日：2014-10-21
• US8933073B2
  申请人：——

  公开号：US8933073B2

  公开（公告）日：2015-01-13